Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

12.5%

1 terminated/withdrawn out of 8 trials

Success Rate

83.3%

-3.2% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

60%

3 of 5 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

N/A

6(85.7%)

Phase 1

1(14.3%)

7Total

N/A(6)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT05656833Not ApplicableUnknown

Combination Topical Cysteamine and Fractional 1927nm Low-Powered Diode Laser for Treatment of Facial Melasma

Role: collaborator

NCT04606368Not ApplicableCompleted

Bausch Health Thermage FXL for Use on Lower Face and Submentum Area

Role: collaborator

NCT01842373Not ApplicableWithdrawn

Comparison Study on Topical Anesthetic Agents (LMX4 and BLT) Prior to Fractional Skin Resurfacing

Role: collaborator

NCT01853397Not ApplicableCompleted

Evaluation of the Treatment of Adipose Tissue With Liposonix System (Model 2) Using a New Treatment Method

Role: lead

NCT01823653Not ApplicableCompleted

Treatment of Subcutaneous Adipose Tissue in the Thighs Using High Intensity Focused Ultrasound

Role: lead

NCT01993238Not ApplicableCompleted

Evaluation of Procedural Analgesia for Liposonix Treatment

Role: lead

NCT01257555Completed

Evaluation of a Photopneumatic System for the Treatment of Acne

Role: lead

NCT01005992Phase 1Unknown

Fractional Photothermolysis for the Treatment of Burn Scars

Role: collaborator

All 8 trials loaded